Obatala Sciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 16

Obatala Sciences General Information

Description

Developer of an in vitro humanized adipose tissue model system designed to simplify tissue engineering for drug discovery. The company's system is a three-dimensional screening tool used for disease modeling, cell assays, cell identification, tissue analysis, and drug discovery, enabling academic and pharmaceutical researchers to identify effective drug compounds and reduce the time, money, and effort required in testing potential drugs to treat obesity, diabetes other metabolic diseases, and related cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2000 Lakeshore Drive
  • Suite 4020
  • New Orleans, LA 70148
  • United States
+1 (504)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 2000 Lakeshore Drive
  • Suite 4020
  • New Orleans, LA 70148
  • United States
+1 (504)

Obatala Sciences Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Obatala Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 01-Jul-2023 Completed Generating Revenue
9. Later Stage VC (Series A) 15-Sep-2022 Completed Generating Revenue
8. Later Stage VC Cancelled Generating Revenue
7. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
6. Early Stage VC 30-Sep-2020 Completed Generating Revenue
5. Accelerator/Incubator 03-Jul-2020 Completed Startup
4. Accelerator/Incubator 01-Jan-2020 Completed Startup
3. Grant 25-Apr-2019 Completed Startup
2. Grant 01-Jan-2019 $1.35M Completed Startup
1. Grant 05-Sep-2017 $250K Completed Startup
To view Obatala Sciences’s complete valuation and funding history, request access »

Obatala Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an in vitro humanized adipose tissue model system designed to simplify tissue engineering for drug discover
Biotechnology
New Orleans, LA
13 As of 2024

Paris, France
 

Hayward, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Obatala Sciences Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eligo Bioscience Venture Capital-Backed Paris, France
Biolog Venture Capital-Backed Hayward, CA
RoosterBio Venture Capital-Backed Frederick, MD
Quantapore Venture Capital-Backed South San Francisco, CA
Scipher Medicine Venture Capital-Backed Waltham, MA
You’re viewing 5 of 29 competitors. Get the full list »

Obatala Sciences Patents

Obatala Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3579844-A2 Biological scaffolds, products containing biological scaffolds and methods of using the same Pending 10-Feb-2017
EP-3579844-A4 Biological scaffolds, products containing biological scaffolds and methods of using the same Pending 10-Feb-2017
US-20200078411-A1 Biological scaffolds, products containing biological scaffolds and methods of using the same Pending 10-Feb-2017 A61K35/35

Obatala Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Obatala Sciences Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Corridor Ventures (New Orleans) Venture Capital Minority
Benson Capital Partners Venture Capital Minority
être Venture Capital Venture Capital Minority
Hackett Robertson Tobe Group Asset Manager Minority
Ochsner Lafayette General Corporation Minority
You’re viewing 5 of 16 investors. Get the full list »

Obatala Sciences Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
LaCell 01-Jan-2020 Other Pharmaceuticals and Biotechnology
To view Obatala Sciences’s complete acquisitions history, request access »

Obatala Sciences FAQs

  • When was Obatala Sciences founded?

    Obatala Sciences was founded in 2017.

  • Where is Obatala Sciences headquartered?

    Obatala Sciences is headquartered in New Orleans, LA.

  • What is the size of Obatala Sciences?

    Obatala Sciences has 13 total employees.

  • What industry is Obatala Sciences in?

    Obatala Sciences’s primary industry is Biotechnology.

  • Is Obatala Sciences a private or public company?

    Obatala Sciences is a Private company.

  • What is Obatala Sciences’s current revenue?

    The current revenue for Obatala Sciences is .

  • How much funding has Obatala Sciences raised over time?

    Obatala Sciences has raised $4.25M.

  • Who are Obatala Sciences’s investors?

    Corridor Ventures (New Orleans), Benson Capital Partners, être Venture Capital, Hackett Robertson Tobe Group, and Ochsner Lafayette General are 5 of 16 investors who have invested in Obatala Sciences.

  • Who are Obatala Sciences’s competitors?

    Eligo Bioscience, Biolog, RoosterBio, Quantapore, and Scipher Medicine are some of the 29 competitors of Obatala Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »